[Sar9,Met(O2)11]-Substance P TFA
目录号: PL07713 纯度: ≥98%
商品编号 规格 价格 会员价 是否有货 数量
PL07713-1mg 1mg ¥1224.00 请登录
PL07713-5mg 5mg ¥4821.82 请登录
PL07713-10mg 10mg ¥8530.91 请登录
PL07713-25mg 25mg ¥17309.09 请登录
PL07713-50mg 50mg 询价 询价
PL07713-100mg 100mg 询价 询价
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
中文名称
[Sar9,Met(O2)11]-Substance P TFA
英文名称
[Sar9,Met(O2)11]-Substance P TFA
包装储存
Sealed storage, away from moisturePowder -80°C 2 years;-20°C 1 year
产品详情
[Sar9,Met(O2)11]-Substance P TFA 是一种选择性的速激肽 NK1 受体激动剂。
生物活性
[Sar9,Met(O2)11]-Substance P TFA is a tachykinin NK 1 receptor selective agonist.
性状
Solid
IC50 & Target[1][2]
NK1 receptor
体外研究(In Vitro)
[Sar9,Met(O2)11]-Substance P and septide (10-100?pmol per rat, i.c.v.) are equipotent in increasing mean arterial blood pressure (MAP) and heart rate (HR), yet they have dissimilar time-course. Both agonists increase dose-dependently face washing and sniffing while [Sar9,Met(O2)11]-Substance P is the sole to produce grooming. has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Sealed storage, away from moisturePowder -80°C 2 years;-20°C 1 year
SequenceShortening
RPKPQQFF-{Sar}-LM[O2]-NH2
Sequence
Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-{Sar}-Leu-Met[O2]-NH2
参考文献
[1]. Cellier E, et al. Characterization of central and peripheral effects of septide with the use of five tachykinin NK1 receptor antagonists in the rat. Br J Pharmacol. 1999 Jun;127(3):717-28.
溶解度数据
In Vitro: H2O : 100 mg/mL (66.33 mM; Need ultrasonic)配制储备液
搜索质检报告(COA)

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2